Skip to main content
Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.640
-0.050 (-2.98%)
Nov 21, 2024, 2:04 PM EST - Market open

Protalix BioTherapeutics Revenue

Protalix BioTherapeutics had revenue of $17.96M in the quarter ending September 30, 2024, with 73.60% growth. This brings the company's revenue in the last twelve months to $45.67M, down -28.22% year-over-year. In the year 2023, Protalix BioTherapeutics had annual revenue of $65.49M with 37.48% growth.

Revenue (ttm)
$45.67M
Revenue Growth
-28.22%
P/S Ratio
2.71
Revenue / Employee
$219,553
Employees
208
Market Cap
120.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202365.49M17.86M37.48%
Dec 31, 202247.64M9.29M24.22%
Dec 31, 202138.35M-24.55M-39.03%
Dec 31, 202062.90M8.21M15.00%
Dec 31, 201954.69M20.45M59.73%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

PLX News

More News